QQ客服 官方微博 反馈留言

	Inhibiting CB1 receptors improves lipogenesis in an in vitro non-alcoholic fatty liver disease model
	Shi, Dongmei; Zhan, Xi; Yu, Xiaofeng; Jia, Minglei; Zhang, Ying; Yao, Jianfeng; Hu, Xiaona; Bao, Zhijun
刊名	LIPIDS IN HEALTH AND DISEASE
	2014
卷号	13
关键词	Endocannabinoids (ECs) Lipogenesis Nonalcoholic fatty liver disease (NAFLD) Receptor cannabinoid (CB1,CB2)
ISSN号	1476-511X
URL标识	查看原文
语种	英语
内容类型	期刊论文
URI标识	http://www.corc.org.cn/handle/1471x/4888678
专题	复旦大学上海医学院
推荐引用方式 GB/T 7714	Shi, Dongmei,Zhan, Xi,Yu, Xiaofeng,et al. Inhibiting CB1 receptors improves lipogenesis in an in vitro non-alcoholic fatty liver disease model[J]. LIPIDS IN HEALTH AND DISEASE,2014,13.
APA	Shi, Dongmei.,Zhan, Xi.,Yu, Xiaofeng.,Jia, Minglei.,Zhang, Ying.,...&Bao, Zhijun.(2014).Inhibiting CB1 receptors improves lipogenesis in an in vitro non-alcoholic fatty liver disease model.LIPIDS IN HEALTH AND DISEASE,13.
MLA	Shi, Dongmei,et al."Inhibiting CB1 receptors improves lipogenesis in an in vitro non-alcoholic fatty liver disease model".LIPIDS IN HEALTH AND DISEASE 13(2014).

个性服务

查看访问统计

相关权益政策

暂无数据

收藏/分享

除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。